Home / Generics

Generics

News

EMA approves hypertension and Parkinson’s generics posted 17/05/2019

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 26 April 2019 that i...

Stada launches generic Exforge following patent revocation posted 19/04/2019

German generics producer Stada Arzneimittel announced on 20 March 2019 that it is set to launch a generic version of the anti...

FDA approves generics from Amneal and Dr Reddy’s, and Natco submits ANDA posted 22/03/2019

In January 2019, the US Food and Drug Administration (FDA) approved Amneal Pharmaceutical’s (Amneal) generic Exelon patch and...

Mylan launches Advair generic at 70% discount posted 04/03/2019

US-based drugmaker Mylan announced on 12 February 2019 the launch of Wixela Inhub (fluticasone/salmeterol inhalation powder,...

Zydus gets FDA approval for skin, heart and acid reflux generics posted 15/02/2019

Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market betamethasone dipropionate...

 

Research

Adherence to generic versus brand-name statins and associated clinical and economic outcomes posted 24/05/2019

Despite evidence supporting the efficacy of statins for the treatment and prevention of cardiovascular disease, a lack of adh...

Costs and prices of entecavir to treat Hepatitis B posted 17/05/2019

In an analysis of the costs and target prices of Hepatitis B treatment entecavir, author Andrew Hill from Liverpool Universit...

Mixed beliefs about generics among patients in a Malaysian hospital posted 03/05/2019

The Malaysian Government is heavily subsidizing public healthcare expenditure in order to provide access to health care for a...

Market evolution of new drug formulations posted 01/04/2019

Brand-name drug manufacturers sometimes create modified versions of their approved drugs which can include new strengths, dos...

Factors associated with increased side effects and lower perceived efficacy when switching to a generic posted 22/03/2019

In 2017, the New Zealand Pharmaceutical Management Agency (PHARMAC) changed the funded version of the antidepressant venlafax...

 

General

Multi-state lawsuit alleges widespread generic price fixing in the US posted 20/05/2019

A sweeping lawsuit filed on 10 May 2019 by over 40 US states alleges that a number of major drug companies conspired to infla...

US Court rejects Teva’s lawsuit over generic Restasis posted 08/05/2019

The US District Court for the District of Columbia has discarded lawsuits from generics giant Teva Pharmaceutical Industries...

FDA releases statement on generic drug quality posted 15/04/2019

A statement released by the US Food and Drug Administration (FDA) responds to recent press reports of quality issues and outl...

Spotlight on the role of pharmacy benefit managers in the fight against rising drug prices posted 05/04/2019

High prices of prescriptions have become a major issue for patients and politicians in the US. In addition to scrutiny of pha...

Pilot procurement scheme in China cuts drug prices posted 08/03/2019

The Chinese pharmaceutical market, which is dominated by domestic manufacturers, is the second largest in the world in terms...